The article investigates the alarming side effects associated with Elmiron, a medication prescribed for interstitial cystitis. Retinal specialist Nieraj Jain discovered a new cause of blindness termed pigmentary maculopathy in multiple patients taking the drug. Concurrently, patients were also diagnosed with severe colitis. By 2024, reports indicated that hundreds suffered vision loss or blindness while others faced life-threatening complications. With dozens of deaths linked to Elmiron, the article highlights the urgent need for further research into the drug's safety and efficacy, particularly given the lack of supportive evidence for its continued prescription.
Nieraj Jain, a retinal specialist, found an alarming pattern: multiple patients on Elmiron developed a condition called pigmentary maculopathy, leading to vision loss.
Despite widespread use of Elmiron for interstitial cystitis, no solid evidence exists to support its safety or efficacy, raising serious concerns regarding its prescription.
Collection
[
|
...
]